# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Primary progressive aphasia

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 21-30 of 189 results.
Gamma-Induction in FrontoTemporal Dementia Trial
Status: Recruiting
Last Changed: Sep 15, 2020
First Received: Jun 11, 2020
Disease(s): Frontotemporal Dementia
Intervention(s): Transcranial Alternating Current Stimulation (tACS), Sham Transcranial Alternating Current Stimulation (sham tACS)
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
Status: Completed
Last Changed: Aug 03, 2020
First Received: Feb 26, 2015
Disease(s): Familial Frontotemporal Dementia
Locations: University of California, San Francisco, Memory and Aging Center, Department of Neurology, San Francisco, California, United States
Mayo Clinic Florida, Jacksonville, Florida, United States
Harvard University, Charlestown, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University, Saint Louis, Missouri, United States
... and 4 other locations.
PPA Tele-Savvy: A Pilot Study of an Online Intervention for Caregivers of Persons Living With PPA
Status: Recruiting
Last Changed: Aug 20, 2020
First Received: Jun 02, 2020
Disease(s): Primary Progressive Aphasia, Caregiver Burnout
Intervention(s): PPA Tele-Savvy Pilot Intervention
Locations: Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University, Chicago, Illinois, United States
Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia
Status: Completed
Last Changed: Jun 04, 2012
First Received: Jan 16, 2008
Disease(s): Frontotemporal Dementia
Intervention(s): memantine hydrochloride
Locations: Baycrest, Toronto, Ontario, Canada
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)
Status: Recruiting
Last Changed: Sep 01, 2020
First Received: May 05, 2020
Disease(s): Frontotemporal Dementia
Intervention(s): AL001, Placebo
Locations: Dignity Health, Phoenix, Arizona, United States
University of California San Diego, La Jolla, California, United States
University of California San Francisco, San Francisco, California, United States
University of Colorado, Aurora, Colorado, United States
Emory University, Atlanta, Georgia, United States
... and 43 other locations.
Can Magnetic Brain Stimulation Improve Language Function in Primary Progressive Aphasia
Status: Recruiting
Last Changed: Aug 14, 2020
First Received: Dec 10, 2019
Disease(s): Logopenic Progressive Aphasia
Intervention(s): MagStim Rapid2 Transcranial Magnetic Simulation
Locations: St. Boniface Hospital, Winnipeg, Manitoba, Canada
A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)
Status: Recruiting
Last Changed: Sep 02, 2020
First Received: Jun 17, 2019
Disease(s): Frontotemporal Dementia
Intervention(s): AL001
Locations: University of Alabama, Birmingham, Alabama, United States
UCSF, San Francisco, California, United States
Mayo Clinic, Rochester, Minnesota, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Lawson Health Research Institute, St. Joseph's, London, Ontario, Canada
... and 7 other locations.
Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial
Status: Recruiting
Last Changed: Jul 28, 2020
First Received: Jul 28, 2020
Disease(s): Frontotemporal Dementia
Intervention(s): PEA-LUT, PLACEBO
Locations: Giacomo Koch, Rome, Italy
Santa Lucia Foundation, Rome, Italy
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Status: Completed
Last Changed: Feb 22, 2018
First Received: Apr 28, 2014
Disease(s): Neimann-Pick Disease
Intervention(s): Vorinostat
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Completed
Last Changed: Mar 14, 2018
First Received: Jun 22, 2012
Disease(s): Behavioral Variant Frontotemporal Dementia (bvFTD)
Intervention(s): TRx0237, Placebo
Locations: David Geffen School of Medicine at UCLA, UCLA Neurological Services, Los Angeles, California, United States
The Shankle Clinic, Newport Beach, California, United States
Memory and Aging Centre, San Francisco, California, United States
Meridien Research, Brooksville, Florida, United States
Mayo Clinic, Jacksonville, Florida, United States
... and 63 other locations.